发布求助
文献互助 智能选刊 最新文献

Clinical Lymphoma Myeloma and Leukemia最新文献

筛选
英文 中文
POSTER: ALL-555 Acute Lymphocytic Leukemia in Pregnancy, Case Report and Review of the Literature 海报:ALL-555急性淋巴细胞白血病在妊娠，病例报告和文献回顾
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00402-0
Mariam Aldarweesh, Eman Alazmi, F. Khadadah, Hadeel Al-Enezi, Ahmed El-Sheashaey, E. Vlachodimitropoulou, A. Alhuraiji, R. Pandita
{"title":"POSTER: ALL-555 Acute Lymphocytic Leukemia in Pregnancy, Case Report and Review of the Literature","authors":"Mariam Aldarweesh, Eman Alazmi, F. Khadadah, Hadeel Al-Enezi, Ahmed El-Sheashaey, E. Vlachodimitropoulou, A. Alhuraiji, R. Pandita","doi":"10.1016/s2152-2650(23)00402-0","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00402-0","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"110 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85671070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience 海报:CT-230评估异体干细胞移植(alloo - sct)后BK多瘤病毒感染频率和危险因素:单中心经验
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00888-1
Barış Gezici, N. Soyer, Ajda Güneş, G. Saydam, M. Töbü, F. Şahin, F. Vural
{"title":"POSTER: CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience","authors":"Barış Gezici, N. Soyer, Ajda Güneş, G. Saydam, M. Töbü, F. Şahin, F. Vural","doi":"10.1016/s2152-2650(23)00888-1","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00888-1","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"229 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76811710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IBCL-492 A Cost-Effectiveness Analysis of Mosunetuzumab for Treatment of Thirdor Higher-Line Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US) IBCL-492:美国Mosunetuzumab治疗三线复发或难治性(R/R)滤泡性淋巴瘤(FL)的成本-效果分析
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01365-4
M. Matasar, Javier Sanchez Alvarez, Hélène Parisé, Eric Zuk, D. D. Maio, S. Shapouri, Eunice Kim, Shih-Wen Lin
{"title":"IBCL-492 A Cost-Effectiveness Analysis of Mosunetuzumab for Treatment of Thirdor Higher-Line Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in the United States (US)","authors":"M. Matasar, Javier Sanchez Alvarez, Hélène Parisé, Eric Zuk, D. D. Maio, S. Shapouri, Eunice Kim, Shih-Wen Lin","doi":"10.1016/s2152-2650(23)01365-4","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01365-4","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82982658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABCL-620 Exploring Sexual Dysfunction and Sexual Distress in Patients With Lymphoma During Cancer Treatment ABCL-620探讨淋巴瘤患者在癌症治疗期间的性功能障碍和性困扰
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01340-x
Dorothie Durosier Mertilus, Carmen Rodriguez, Sara M. Tinsley-Vance, R. Komrokji
{"title":"ABCL-620 Exploring Sexual Dysfunction and Sexual Distress in Patients With Lymphoma During Cancer Treatment","authors":"Dorothie Durosier Mertilus, Carmen Rodriguez, Sara M. Tinsley-Vance, R. Komrokji","doi":"10.1016/s2152-2650(23)01340-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01340-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85386561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study ABCL-478 Glofitamab用于复发/难治性弥漫性大b细胞淋巴瘤患者，既往治疗≥2次:来自关键II期扩展研究的结果
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01325-3
M. Dickinson, C. Carlo-Stella, F. Morschhauser, E. Bachy, P. Corradini, G. Iacoboni, C. Khan, T. Wrobel, F. Offner, M. Trněný, Shang-Ju Wu, G. Cartron, M. Hertzberg, A. Sureda, D. Pérez-Callejo, L. Lundberg, J. Relf, E. Clark, K. Humphrey, M. Hutchings
{"title":"ABCL-478 Glofitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies: Results From a Pivotal Phase II Expansion Study","authors":"M. Dickinson, C. Carlo-Stella, F. Morschhauser, E. Bachy, P. Corradini, G. Iacoboni, C. Khan, T. Wrobel, F. Offner, M. Trněný, Shang-Ju Wu, G. Cartron, M. Hertzberg, A. Sureda, D. Pérez-Callejo, L. Lundberg, J. Relf, E. Clark, K. Humphrey, M. Hutchings","doi":"10.1016/s2152-2650(23)01325-3","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01325-3","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84147628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HL-007 The Role of Interim Positron Emission Tomography (PET)/Computed Tomography (CT) Scans in the Management of Hodgkin Lymphoma: A Single-Center Study in a Developing Country HL-007正电子发射断层扫描(PET)/计算机断层扫描(CT)在治疗霍奇金淋巴瘤中的作用:一个发展中国家的单中心研究
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01263-6
S. Azeez, Ahmed K. Yassin, Nasherwan Sadiq
{"title":"HL-007 The Role of Interim Positron Emission Tomography (PET)/Computed Tomography (CT) Scans in the Management of Hodgkin Lymphoma: A Single-Center Study in a Developing Country","authors":"S. Azeez, Ahmed K. Yassin, Nasherwan Sadiq","doi":"10.1016/s2152-2650(23)01263-6","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01263-6","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78314851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: ABCL-515 Updated Results of the Safety Run-In of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL 海报:ABCL-515 3期LOTIS-5试验安全性试验的最新结果:Loncastuximab Tesirine与Rituximab (Lonca-R)的新型联合治疗与免疫化疗治疗R/R DLBCL患者
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00729-2
M. Kwiatek, S. Grosicki, Javier López Jiménez, Sergio Felipe Pinzón Mariño, S. Snauwaert, E. Kingsley, Giovanna Zacchetti, Ying Wang, Luqiang Wang, J. Depaus
{"title":"POSTER: ABCL-515 Updated Results of the Safety Run-In of the Phase 3 LOTIS-5 Trial: Novel Combination of Loncastuximab Tesirine With Rituximab (Lonca-R) Versus Immunochemotherapy in Patients With R/R DLBCL","authors":"M. Kwiatek, S. Grosicki, Javier López Jiménez, Sergio Felipe Pinzón Mariño, S. Snauwaert, E. Kingsley, Giovanna Zacchetti, Ying Wang, Luqiang Wang, J. Depaus","doi":"10.1016/s2152-2650(23)00729-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00729-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"182 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73368332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: MPN-571 Effect of New or Worsening Anemia on Clinical Outcomes in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX): A Post Hoc Analysis of the COMFORT-I and -II Trials 新发或恶化贫血对接受Ruxolitinib (RUX)治疗的骨髓纤维化(MF)患者临床结局的影响:COMFORT-I和-II试验的事后分析
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00663-8
H. Al-Ali, Ruben A. Mesa, J. Hamer-Maansson, Evan Braunstein, C. Harrison
{"title":"POSTER: MPN-571 Effect of New or Worsening Anemia on Clinical Outcomes in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX): A Post Hoc Analysis of the COMFORT-I and -II Trials","authors":"H. Al-Ali, Ruben A. Mesa, J. Hamer-Maansson, Evan Braunstein, C. Harrison","doi":"10.1016/s2152-2650(23)00663-8","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00663-8","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76930229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-284 Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting AML-284 Venetoclax联合低甲基化药物或低剂量阿糖胞苷治疗复发/难治性npm1突变的急性髓系白血病:来自现实环境的临床经验
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01030-3
M. Piccini, G. Gianfaldoni, F. Mannelli, B. Scappini, Gaia Ciolli, Andrea Pasquini, Laura Fasano, S. Pilerci, E. Quinti, F. Crupi, P. Guglielmelli, A. Vannucchi
{"title":"AML-284 Venetoclax in Combination With Hypomethylating Agents or Low-Dose Cytarabine for Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia: Clinical Experience From a Real-Life Setting","authors":"M. Piccini, G. Gianfaldoni, F. Mannelli, B. Scappini, Gaia Ciolli, Andrea Pasquini, Laura Fasano, S. Pilerci, E. Quinti, F. Crupi, P. Guglielmelli, A. Vannucchi","doi":"10.1016/s2152-2650(23)01030-3","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01030-3","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76948536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-446 Time to Resolution of Myelosuppression and Associated Hospitalization in Patients With Newly-Diagnosed Acute Myeloid Leukemia (AML) Treated With Ivosidenib (IVO) + Azacitidine (AZA) Compared to Placebo (PBO) + AZA 与安慰剂(PBO) + AZA相比，Ivosidenib (IVO) + Azacitidine (AZA)治疗新诊断急性髓系白血病(AML)患者的骨髓抑制消退时间和相关住院治疗
Clinical Lymphoma Myeloma and Leukemia Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01062-5
A. Fathi, B. D. Smith, A. Angiolillo, G. Binder, J. Hui, Rachel Guo, C. Cerchione
{"title":"AML-446 Time to Resolution of Myelosuppression and Associated Hospitalization in Patients With Newly-Diagnosed Acute Myeloid Leukemia (AML) Treated With Ivosidenib (IVO) + Azacitidine (AZA) Compared to Placebo (PBO) + AZA","authors":"A. Fathi, B. D. Smith, A. Angiolillo, G. Binder, J. Hui, Rachel Guo, C. Cerchione","doi":"10.1016/s2152-2650(23)01062-5","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01062-5","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82287708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信